
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 240
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | ||
NCT05135260 | Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic | ||
NCT02057874 | 3-Tesla MRI Response to TACE in HCC (Liver Cancer) | ||
NCT02170272 | Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors | ||
NCT05361720 | Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study | ||
NCT02685631 | Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study | ||
NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | ||
NCT01396382 | 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer | ||
NCT03607682 | Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer | ||
NCT00482365 | National Registry and Blood Bank of Patients With Liver Cancer | ||
NCT02374931 | 18F-FES PET/CT in Imaging Patients With Desmoid Tumors | ||
NCT05770531 | Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy | ||
NCT01882231 | Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma | ||
NCT05501665 | Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | ||
NCT05734430 | Genetics of Appendix Cancer Study | ||
NCT00544648 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | ||
NCT00930930 | Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer | ||
NCT00898430 | Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy | ||
NCT02493530 | TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea | ||
NCT00837876 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | ||
NCT03238248 | Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors | ||
NCT06482957 | Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | ||
NCT00899457 | Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants | ||
NCT00483457 | Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients | ||
NCT01996527 | 3T MRI Biomarkers of Glioma Treatment Response | ||
NCT05747625 | (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma | ||
NCT02448225 | 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules | ||
NCT04299425 | Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy | ||
NCT06110572 | Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation | ||
NCT00899301 | Collecting and Storing Tissue Samples From Women With or Without Breast Cancer | ||
NCT04354701 | COVID-19 and Cancer Consortium Registry | ||
NCT00573404 | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors | ||
NCT01901367 | ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients | ||
NCT00656604 | Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | ||
NCT00474604 | Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | ||
NCT06105801 | EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing | ||
NCT01316692 | Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma | ||
NCT02576444 | OLAParib COmbinations | ||
NCT00006104 | Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer | ||
NCT04765072 | Expanding Rural Health Cancer Control Capacity | ||
NCT03023904 | Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads | ||
NCT03263429 | Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer | ||
NCT04250194 | Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration | ||
NCT03231891 | Inherited CAncer REgistry | ||
NCT00896662 | Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | ||
NCT05156060 | Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer | ||
NCT01928160 | Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib | ||
NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | ||
NCT00503776 | Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia | ||
NCT00898027 | Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer |